Connection
David Wyles to Enzyme-Linked Immunosorbent Assay
This is a "connection" page, showing publications David Wyles has written about Enzyme-Linked Immunosorbent Assay.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.028 |
|
|
|
-
Grebely J, Mauss S, Brown A, Bronowicki JP, Puoti M, Wyles D, Natha M, Zhu Y, Yang J, Kreter B, Brainard DM, Yun C, Carr V, Dore GJ. Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials. Clin Infect Dis. 2016 Dec 01; 63(11):1405-1411.
Score: 0.028